Context The optimal timing to performing thyroid surgery following a diagnosis of papillary
thyroid cancer (PTC) has yet to be fully defined. Objective We aimed to examine if a delayed …

Objective It remains unclear whether the time interval between total thyroidectomy and
radioactive iodine therapy (RAIT) affects clinical outcomes in papillary thyroid carcinoma …

Background It remains unclear whether the time interval between total thyroidectomy and
radioactive iodine (RAI) therapy influences clinical outcomes in papillary thyroid carcinoma …

Objective: Postthyroidectomy radioiodine (RAI) therapy is indicated for papillary thyroid
carcinoma (PTC) with high-risk features. There is variability in the timing of RAI therapy with …

Background: This study validated the dynamic risk stratification (DRS) system with regard to
its association with structural recurrence and risk factors associated with non-excellent …

Context The waiting time for radioactive iodine therapy (WRAIT) after total thyroidectomy
(TT) in patients with papillary thyroid cancer (PTC) and lymph node metastases (N1) has not …

Background Papillary thyroid carcinoma (PTC) is generally associated with favorable
outcomes; however, intermediate-risk requires further evaluation. We therefore examined …

Purpose This study aimed to evaluate the efficacy of postoperative radioactive iodine (RAI)
and its impact on recurrence rates and survival benefits in low-to intermediate-risk papillary …

Background To investigate whether post-treatment recurrence differs by tumor size or
surgical extent in clinically early-stage papillary thyroid carcinoma (PTC) patients. Methods …

Background Patients with intermediate‐risk papillary thyroid carcinoma (PTC) have a
favorable prognosis with standard treatment of total thyroidectomy (TT) and adjuvant …